Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington’s intensifying drug-pricing push

As officials in Washington weigh contentious drug-pricing measures, there’s even more evidence that pharma companies are worried about potential reform. In an open letter to Congress, the heads of major biopharma companies including Eli Lilly, AbbVie, Bristol Myers Squibb, Biogen, GlaxoSmithKline and many more wrote that one proposal in particular—allowing Medicare to negotiate drug prices—would “threaten patients’ access […]

Citing ‘less-than-optimal’ outcomes for Roche’s Evrysdi, Biogen launches high-dose Spinraza trial

While much of the attention on Biogen lately has centered on its launch of controversial Alzheimer’s disease drug Aduhelm, the company is also feeling the heat from a new challenger in spinal muscular atrophy (SMA).  Biogen’s Spinraza, an SMA drug launched in early 2017, is facing new competition from Roche’s 2020 oral entrant Evrysdi. After analyzing […]

AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit

AbbVie faced no shortage of criticism and questioning over its decision to abandon its proposed $55 billion Shire buyout back in 2014. But after years of legal back-and-forth, the company has escaped one high-profile case from hedge funds that alleged the company misled them about its true intentions. When AbbVie unveiled its proposed Shire deal in July 2014, the […]

Biohaven’s ambitious Nurtec ODT marketing strategy pays dividends with doctors in migraine market: analyst

Biohaven went all-in on marketing its added preventative indication for oral migraine med Nurtec. And now it’s reaping the rewards with doctors. Three months post-approval, 96% of neurologists were aware of the brand, while 65% are “highly familiar” with it, according to Spherix Global Insights’ postlaunch report. Nurtec easily bested bigger migraine players postlaunch familiarity including Amgen’s […]

Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says

Takeda is helping Moderna and Novavax make their COVID-19 vaccines available in Japan. With those new products and about a decade’s worth of progress on its dengue shot under its belt, Takeda’s CEO sees vaccines becoming a bigger part of the drugmaker’s business going forward. A vaccine business, “when established, has a very long life,” […]

Bayer pharma goes all-in for digital media buying, moving external operations in-house

In an increasingly digital world, information is king. And managing data is a big reason Bayer is moving its digital media buying in-house. The move from the pharma business follows its consumer group sibling Bayer Consumer Health Division’s switch to in-house digital media buying more than two years ago. For Bayer, even more important than the obvious […]

Eylea-maker Regeneron looks to raise eye health awareness with ‘Now Eye See’ campaign

While Regeneron’s new awareness campaign comes with a lighthearted pun title, “Now Eye See” addresses a serious problem for people with diabetes. Diabetic retinopathy is the most common eye complication and a leading cause of blindness in the U.S. An animated TV ad explains the connection between diabetes and eyesight, warning that high blood sugar […]

Departing FDA officials say it’s too soon for COVID-19 boosters as White House plans rollout next week

Does the general U.S. population need COVID-19 boosters? A group of renowned global health experts, including two key departing vaccine authorities at the FDA, don’t think so. Even with the wave of delta variant-driven coronavirus cases in the U.S., the authorized vaccines appear to be staving off severe infections, according to a paper published in The […]

On heels of one expansion, J&J will pour $176M into another boost for its manufacturing site in Ireland

Johnson & Johnson’s manufacturing site in Ringaskiddy, Ireland, keeps growing. After completing a €300 million ($354 million) expansion in 2019, the company has plans to further boost the capacity of the site. J&J’s subsidiary Janssen has submitted a planning application to the County Cork Council which would add 27,000 square feet and 180 employees, the Sunday Independent […]

Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts

While Congress and the U.S. government have sought to lower drug prices for years, the issue appears to be coming to a head once again in Washington, D.C. The proposals that officials are eyeing aren’t new, but they could have outsized effects on some of the industry’s largest players. Analyzing the potential effects of drug […]

Pharma’s JAK drugs could suffer in rheumatoid arthritis, atopic dermatitis. How do FDA warnings affect other inflammatory uses?

After the FDA last week slapped safety warnings and use restrictions on AbbVie’s Rinvoq, Eli Lilly’s Olumiant and Pfizer’s Xeljanz, Wall Street has started rethinking its calculations for the JAK inhibitor class. Based on discussions with three industry experts, analysts with SVB Leerink believe the FDA’s warning could have a range of effects on the meds’ […]

From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year

This year has already witnessed a handful of memorable FDA approvals. And if one thing’s clear, the pandemic hasn’t slowed biopharma’s ability to push prospects over the agency’s finish line. There’s been Biogen’s historic and controversial accelerated approval for Aduhelm in Alzheimer’s disease. That’s not to mention Amgen’s closely watched nod for Lumakras, the first lung […]